New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
07:29 EDTNBIXNeurocrine volatility may move on positive phase 2b study
Neurocrine option implied volatility may pick up following positive results of NBI-98854 in Kinect 2 study. Overall option implied volatility of 75 compares to its 26-week average of 79 according to Track Data, suggesting decreasing price movement.
News For NBIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 23, 2015
10:41 EDTNBIXNeurocrine management to meet with Piper Jaffray
Subscribe for More Information
February 19, 2015
07:07 EDTNBIXNeurocrine 6.944M share Secondary priced at $36.00
Subscribe for More Information
February 17, 2015
18:36 EDTNBIXOn The Fly: After Hours Movers
Subscribe for More Information
16:09 EDTNBIXNeurocrine files to sell $225M in common stock
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use